SEARCH

SEARCH BY CITATION

Receive a continuing education certificate immediately by visiting http://www.jmwhce.org to take the test, complete the evaluation, and pay processing fees online.

CONTINUING EDUCATION CREDIT INFORMATION

  1. Top of page
  2. CONTINUING EDUCATION CREDIT INFORMATION
  3. FORM INSTRUCTIONS
  4. TEST ANSWERS
  5. EVALUATION
  6. OBJECTIVES
  7. TEST QUESTIONS

This continuing education issue has been approved by the American College of Nurse-Midwives (ACNM) for 2.0 continuing education units (CEUs) inclusive of 2.0 pharmacology CEUs (20 contact hours inclusive of 20 pharmacology contact hours). All continuing education forms must be received by June 30, 2013.

ACNM is an approved provider of CEUs for certified nurse-midwives/certified midwives (CNMs/CMs). ACNM CEUs are accepted for the American Midwifery Certification Board (AMCB) Certificate Maintenance Program (CMP) and for National Certification Corporation (NCC) certification maintenance. Other professional groups may recognize ACNM CEUs as well. Health care providers who are not CNMs/CMs should check with their certifying and licensing agencies.

FORM INSTRUCTIONS

  1. Top of page
  2. CONTINUING EDUCATION CREDIT INFORMATION
  3. FORM INSTRUCTIONS
  4. TEST ANSWERS
  5. EVALUATION
  6. OBJECTIVES
  7. TEST QUESTIONS
  • 1
    Complete this form.
  • 2
    Enclose a check or money order made payable to ACNM or Visa or MasterCard information and mail or fax to:
    American College of Nurse-Midwives
    P.O. Box 759147
    Baltimore, MD 21275-9147
    Fax: 240-485-1818
  • 3
    Participants will receive a CEU certificate in the mail. Please allow 4 weeks for processing. The date on the CEU certificate will be the day remuneration and the completed form are received.
  • 4
    There is a rush fee of $20.00 for immediate processing. All rush orders must be faxed with Visa or MasterCard information to 240-485-1818. Rush orders will be processed within 3 business days after credit card has been charged.

inline image

TEST ANSWERS

  1. Top of page
  2. CONTINUING EDUCATION CREDIT INFORMATION
  3. FORM INSTRUCTIONS
  4. TEST ANSWERS
  5. EVALUATION
  6. OBJECTIVES
  7. TEST QUESTIONS

After reading the articles, fill in the answers to the test questions on the reverse side of this page in the space provided below.

inline image

OBJECTIVES

  1. Top of page
  2. CONTINUING EDUCATION CREDIT INFORMATION
  3. FORM INSTRUCTIONS
  4. TEST ANSWERS
  5. EVALUATION
  6. OBJECTIVES
  7. TEST QUESTIONS

After completion of this continuing education issue, the participant will:

  • 1
    Differentiate pharmacokinetics and pharmacodynamics.
  • 2
    Identify federal legislation relevant to oversight of the pharmaceutical industry and prescriptive authority.
  • 3
    Describe physiologic mechanisms of adverse drug reactions.

TEST QUESTIONS

  1. Top of page
  2. CONTINUING EDUCATION CREDIT INFORMATION
  3. FORM INSTRUCTIONS
  4. TEST ANSWERS
  5. EVALUATION
  6. OBJECTIVES
  7. TEST QUESTIONS

Select the one best answer for each of the multiple choice questions below.

  • 1
    Pharmacodynamics refers to the: (Corbett)
    • a. 
      action the body has on a drug.
    • b. 
      physiologic effects a drug has on body function.
    • c. 
      study of pharmacology and biorhythms.
  • 2
    The Durham-Humphrey Amendment in 1951: (Plank)
    • a. 
      created a regulatory system for controlled substances.
    • b. 
      established the category of prescription drugs.
    • c. 
      prohibited entry of low-quality drugs from overseas.
  • 3
    Adverse drug event reporting in the United States is a: (Tharpe)
    • a. 
      method of identifying causal relationships.
    • b. 
      source of strong epidemiologic evidence.
    • c. 
      voluntary process for health professionals.
  • 4
    In women who undergo labor induction, continuing oxytocin once they progress to active labor: (Simpson)
    • a. 
      decreases the risk of cesarean birth.
    • b. 
      increases the risk of tachysystole.
    • c. 
      shortens labor.
  • 5
    Most clinically relevant opioids have their primary activity at: (Anderson)
    • a. 
      delta receptors.
    • b. 
      kappa receptors.
    • c. 
      mu receptors.
  • 6
    Buprenorphine (Suboxone, Subutex) is: (Goodman)
    • a. 
      not approved for the treatment of opioid dependency during pregnancy.
    • b. 
      only available through federally licensed treatment programs.
    • c. 
      a synthetic opioid with antagonist activity at the mu receptor.
  • 7
    Which of the following drug classes is best for first-line empiric treatment of pyelonephritis in non-pregnant women? (O’Dell)
    • a. 
      Cephalosporins
    • b. 
      Fluoroquinolones
    • c. 
      Macrolides
  • 8
    The most appropriate drug class for long-term, primary care treatment of generalized anxiety disorder is: (Karsnitz & Ward)
    • a. 
      benzodiazepines.
    • b. 
      monoamine oxidase inhibitors (MAOIs).
    • c. 
      selective serotonin reuptake inhibitors (SSRIs).
  • 9
    Abortive migraine medications are: (Moloney)
    • a. 
      the initial management for an acute attack.
    • b. 
      only for patients who have more than 2 migraines per week.
    • c. 
      used when initial pain relief medications do not work.
  • 10
    The best way to monitor the effectiveness of a particular testosterone regimen in a female-to-male (FTM) transgender patient is: (Steinle)
    • a. 
      a mid-cycle serum luteinizing hormone level.
    • b. 
      observation of clinical changes in the patient's body.
    • c. 
      serial serum testosterone levels.

Receive a continuing education certificate immediately by visiting http://www.jmwhce.org to take the test, complete the evaluation, and pay processing fees online.